4073 Results

People

  1. Hudis
    Hudis
  2. Giralt
    Giralt
  3. Gonen
    Gonen
  4. Levine
    Levine
  5. Scher
    Scher
  6. Fong
    Fong
  7. Motzer
    Motzer
  8. Ladanyi
    Ladanyi
  9. Travis
    Travis
  10. Jarnagin
    Jarnagin

Groups

  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)
  7. Department of Pathology and Laboratory Medicine (556)
  8. Center for Hematologic Malignancies (550)
  9. Hematologic Malignancies, Division of (465)
  10. Epidemiology and Biostatistics (464)
  1. "2013"
Formats
  1. Journal Article (2495)
  2. Meeting Abstract (1292)
  3. Book Section (250)
  4. Conference Paper (18)
  5. Book Whole (17)
  6. Review (1)
Groups
  1. Department of Medicine (1421)
  2. GSK Faculty (1000)
  3. Surgery (873)
  4. Solid Tumor Oncology Division (781)
  5. Survivorship Research (671)
  6. Sloan Kettering Institute Faculty (646)

More Groups

People
  1. Jose Baselga (74)
  2. Clifford Hudis (69)
  3. Jedd Wolchok (65)
  4. Howard Scher (62)
  5. Mithat Gonen (62)
  6. Ross Levine (62)

More People

Years
  1. 2013 (4073)
Publications
  1. Journal of Clinical Oncology (366)
  2. Blood (190)
  3. Cancer Research (119)
  4. International Journal of Radiation Oncology, Biology, Physics (88)
  5. Modern Pathology (88)
  6. Laboratory Investigation (81)

More Publications

Publishers
  1. Elsevier Inc. (502)
  2. American Society of Clinical Oncology (386)
  3. Springer (304)
  4. Nature Publishing Group (249)
  5. Elsevier Science, Inc. (206)
  6. American Society of Hematology (192)

More Publishers

Results (4073)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Activity of PU-H71, a novel HSP90 inhibitor, and bortezomib in Ewing sarcoma preclinical models
    Meeting Abstract

    Ambati, S. R.; Lopes, E. C.; Kosugi, K.; Mony, U.; Zehir, A.; Moreira, A. L.; Meyers, P. A.; Chiosis, G.; Moore, M. A. S.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase I study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) in combination with sunitinib, pazopanib, or ipilimumab in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Amin, A.; Ernstoff, M. S.; Infante, J. R.; Heng, D. Y. C.; Rini, B. I.; Plimack, E. R.; McDermott, D. F.; Kollmannsberger, C. K.; Reaume, M. N.; Spratlin, J. L.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Distant metastasis is a critical mode of failure for patients with localized major salivary gland tumors treated with surgery and radiation
    Journal Article

    Tam, M.; Riaz, N.; Salgado, L. R.; Spratt, D. E.; Katsoulakis, E.; Ho, A.; Morris, L. G. T.; Wong, R.; Wolden, S.; Rao, S.; more...
    Journal of Radiation Oncology (2013)

    Fulltext@MSK | Save
  • Multiparameter flow cytometry for detection of minimal residual disease in multiple myeloma after T-cell depleted allogeneic stem cell transplant
    Meeting Abstract

    Kosuri, S.; Smith, K. M.; Kuk, D.; Devlin, S. M.; Maslak, P. G.; Giralt, S.; Koehne, G.
    Blood (2013)

    Fulltext@MSK | Save
  • Pancreatitis in patients treated with brentuximab vedotin: A previously unrecognized serious adverse event
    Meeting Abstract

    Gandhi, M.; Evens, A. M.; Fenske, T. S.; Hamlin, P.; Coiffier, B.; Engert, A.; Moskowitz, A. J.; Ghosh, N.; Petrich, A. M.; Lomasney, J.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Ex vivo expansion of umbilical cord blood CD34+ cells under hypoxic conditions using novel compound #999 with cytokines
    Meeting Abstract

    Khan, S.; Stewart, A. L.; Mukherjee, S.; Scheiber, S. L.; Ebert, B. L.; Golub, T. R.; Scadden, D. T.; Moore, M. A. S.
    Blood (2013)

    Fulltext@MSK | Save
  • ABT-888 plus bendamustine is safe and has shown preliminary efficacy in patients with lymphoma
    Meeting Abstract

    Gerecitano, J. F.; Schwartz, G. K.; Carvajal, R.; Fury, M.; Konner, J.; Hyman, D. M.; Gounder, M.; Gajria, D.; Teitcher, J.; Zhang, Z.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Brentuximab vedotin administered before, during, and after multi-agent chemotherapy in patients (pts) with newly-diagnosed CD30+ mature T- and NK-cell lymphomas
    Meeting Abstract

    Fanale, M. A.; Horwitz, S. M.; Forero-Torres, A.; Bartlett, N. L.; Advani, R. H.; Pro, B.; Chen, R.; Davies, A.; Illidge, T.; Huebner, D.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Intensified mycophenolate mofetil (MMF) dosing every 8 hours is safe from the standpoint of engraftment and may ameliorate severe acute graft-versus-host disease (GVHD) after double-unit cord blood transplantation (CBT)
    Meeting Abstract

    Ponce, D. M.; Harnicar, S. J.; Devlin, S.; Hilden, P.; Evans, K. L.; Lubin, M. N.; Giralt, S. A.; Goldberg, J. D.; Perales, M. A.; Kernan, N. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Allogeneic hematopoietic stem cell transplantation of patients with Wiskott-Aldrich syndrome with total body irradiation (TBI), thiotepa and fludarabine or cyclophosphamide followed By T-cell depleted grafts from alternative donors
    Meeting Abstract

    Prockop, S. E.; Boulad, F.; Kernan, N. A.; Khalif, R.; Kobos, R.; Scaradavou, A.; O'Reilly, R. J.
    Blood (2013)

    Fulltext@MSK | Save